...
首页> 外文期刊>African Journal of Microbiology Research >Prevalence of beta-lactamases in Salmonella and Shigella species in different hospitals in Anyigba, Kogi State, Nigeria
【24h】

Prevalence of beta-lactamases in Salmonella and Shigella species in different hospitals in Anyigba, Kogi State, Nigeria

机译:尼日利亚科吉州安尼格巴不同医院沙门氏菌和志贺氏菌中β-内酰胺酶的流行

获取原文

摘要

Beta-lactams are the most widely used antibiotics. Resistance to beta-lactam antibiotics is an increasing problem worldwide and beta-lactamase production is the most common mechanism of resistance to these drugs. Species of Salmonella and Shigella isolated from hospital patients in Anyigba, Kogi State, were analyzed for the presence of beta–lactamases using Nitrocefin, Iodometric, Acidimetric and Double Disc Synergy methods. Results showed that 9 (81.82%) of Shigella species and 22 (61.11%) of Salmonella species were beta-lactamase producers with 3 (27.27%) of Shigella species and 20 (55.56%) of Salmonella species producing extended spectrum beta-lactamases (ESBLs). Beta-lactamase production is an acknowledged threat to modern medicine especially antibiotic usage.
机译:β-内酰胺类是使用最广泛的抗生素。对β-内酰胺类抗生素的耐药性在世界范围内是一个日益严重的问题,而β-内酰胺酶的生产是对这些药物产生耐药性的最常见机制。使用尼古丁,碘量法,酸度法和双盘协同法对从科吉州安尼格巴的医院患者中分离出的沙门氏菌和志贺氏菌进行了β-内酰胺酶的分析。结果显示,有9(81.82%)志贺氏菌属和22(61.11%)沙门氏菌属是β-内酰胺酶生产者,其中3(27.27%)志贺氏菌属和20(55.56%)沙门氏菌属产生了广谱的β-内酰胺酶( ESBLs)。 β-内酰胺酶的生产是现代医学尤其是抗生素使用的公认威胁。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号